The regulatory action of acetylcholine and its receptors on B4 and C4 leukotriene formation in the porcine endometrium after experimental inflammogenic Escherichia coli infection
29 lis 2024
O artykule
Data publikacji: 29 lis 2024
Zakres stron: 571 - 581
Otrzymano: 21 cze 2024
Przyjęty: 22 lis 2024
DOI: https://doi.org/10.2478/jvetres-2024-0066
Słowa kluczowe
© 2024 Barbara Jana et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Fig. 1.

Fig. 2.

Effects of acetylcholine (ACh) alone or antagonists of muscarinic 2 and 3 receptor subtypes (M2R/M3R) and α-7 nicotinic ACh receptor (α-7 nAChR) alone on leukotriene (LT)B4 and LTC4 secretion from the endometrium of gilts determined by ELISA
Treatment | Group | Concentrations (ng/g tissue) | ||
---|---|---|---|---|
LTB4 | LTC4 | |||
Control value | Control | 2.41 ± 0.14 |
0.85 ± 0.11 |
|
3.37 ± 0.18 |
1.29 ± 0.08 |
|||
ACh | Control | 3.41 ± 017 |
1.45 ± 0.1 |
|
4.25 ± 0.26 |
1.82 ± 0.09 |
|||
M2R antagonist | Control | 2.42 ± 0.23 |
0.98 ± 0.09 |
|
3.26 ± 0.22 |
1.33 ± 0.11 |
|||
M3R antagonist | Control | 2.49 ± 0.15 |
0.81 ± 0.12 |
|
3.09 ± 0.27 |
1.27 ± 0.15 |
|||
α-7 nAChR antagonist | Control | 2.31 ± 0.17 |
0.92 ± 0.07 |
|
2.99 ± 0.26 |
1.16 ± 0.14 |
Western blot results for the effects of acetylcholine (ACh) alone or antagonists of muscarinic 2 and 3 receptor subtypes (M2R/M3R) and α-7 nicotinic ACh receptor (α-7 nAChR) alone on the 5-lipoxygenase (5-LO), leukotriene (LT)A4 hydrolase (LTAH) and LTC4 synthase (LTCS) protein abundances in unchallenged and E_ coli-challenged endometria of gilts
Treatment | Group | Protein expression (arbitrary units) | ||
---|---|---|---|---|
5 LO | LTAH | LTCS | ||
Control value | Control | 0.12 ± 0.01 |
1.82 ± 0.24 |
0.73 ± 0.04 |
0.76 ± 0.12 |
1.71 ± 0.07 |
2.31 ± 0.36 |
||
ACh | Control | 0.65 ± 0.07 |
3.06 ± 0.11 |
2.15 ± 0.09 |
1.63 ± 0.21 |
2.81 ± 0.13 |
5.16 ± 0.42 |
||
M2R antagonist | Control | 0.09 ± 0.01 |
1.91 ± 0.16 |
0.62 ± 0.06 |
0.83 ± 0.09 |
1.23 ± 0.09 |
3.29 ± 0.23 |
||
M3R antagonist | Control | 0.13 ± 0.05 |
1.87 ± 0.08 |
0.54 ± 0.07 |
0.69 ± 0.14 |
1.65 ± 0.11 |
2.86 ± 0.31 |
||
α-7 nAChR antagonist | Control | 0.11 ± 0.08 |
1.41 ± 0.05 |
0.63 ± 0.05 |
0.68 ± 0.15 |
1.48 ± 0.07 |
1.99 ± 0.38 |